Impaired left ventricular synchronicity in patients with metabolic syndrome, regardless of hypertension

Journal of Hypertension

Volumn 27, Issue 4, 2009, Pages 869-875

  Li, Shao Hua ^a,b   Yang, Bo ^a,b   Gong, Hui Ping ^a,b   Tan, Hong Wei ^a,b   Zhong, Ming ^a,b   Zhang, Yun ^a,b   Zhang, Wei ^a,b  

^a Qilu Hospital of Shandong University   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Echocardiography; Metabolic syndrome; Synchronicity; Tissue Doppler imaging

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FILLING; HEART MUSCLE RELAXATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; WAIST HIP RATIO;

EID: 67649671841     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328325d845     Document Type: Article

References (34)

1. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454.
2. Wong CY, O'Moore-Sullivan T, Fang ZY, Haluska B, Leano R, Marwick TH. Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol 2005; 96:1686-1691.
3. Yilmaz R. Do female patients with metabolic syndrome have masked left ventricular dysfunction? Anadolu Kardiyol Derg 2006; 6:89-91.
4. Bleeker GB, Bax JJ, Steendijk P, Schalij MJ, van der Wall EE. Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment. Nat Clin Pract Cardiovasc Med 2006; 3:213-219.
5. Tan HW, Zheng GL, Li L, Wang ZH, Gong HP, Zhang Y, et al. Impaired left ventricular synchronicity in hypertensive patients with ventricular hypertrophy. J Hypertens 2008; 26:553-559.
6. Schuster P, Faerestrand S, Ohm OJ. Color Doppler tissue velocity imaging can disclose systolic left ventricular asynchrony independent of the QRS morphology in patients with severe heart failure. Pacing Clin Electrophysiol 2004; 27:460-467.
7. Yu CM, Lin H, Ho PC, Yang H. Assessment of left and right ventricular systolic and diastolic synchronicity in normal subjects by tissue Doppler echocardiography and the effects of age and heart rate. Echocardiography 2003; 20:19-27.
8. Yu CM, Yang H, Lau CP, Wang Q, Wang S, Lam L, et al. Regional left ventricle mechanical asynchrony in patients with heart disease and normal QRS duration: implication for biventricular pacing therapy. Pacing Clin Electrophysiol 2003; 26:562-570.
9. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Belgium: International Diabetes Federation; 2005.
10. Rotman M, Triebwasser JH. A clinical and follow-up study of right and left bundle branch block. Circulation 1975; 51:477-484.
11. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
12. Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003; 89:54-60.
13. Yu CM, Zhang Q, Yip GW, Lee PW, Kum LC, Lam YY, et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition. J Am Coll Cardiol 2007; 49:97-105.
14. Wang J, Kurrelmeyer KM, Torre-Amione G, Nagueh SF. Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol 2007; 49:88-96.
15. De las Fuentes L, Brown AL, Mathews SJ, Waggoner AD, Soto PF, Gropler RJ, et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 2007; 28:553-559.
16. Farias CA, Rodriguez L, Garcia MJ, Sun JP, Klein AL, Thomas JD. Assessment of diastolic function by tissue Doppler echocardiography: comparison with standard transmural and pulmonary venous flow. J Am Soc Echocardiogr 1999; 12:609-61 7.
17. Yalclin F, Kaftan A, Muderrisoǧlu H, Korkmaz ME, Flachskampf F, Garcia M, et al. Is Doppler tissue velocity during early left ventricular filling preload independent? Heart 2002; 87:336-339.
18. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110:3081-3087.
19. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100:2473-2476.
20. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, et al. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 2004; 43:739-745.
21. Yuda S, Short L, Leano R, Marwick TH. Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: a study of ultrasound tissue characterization and strain. Clin Sci (Lond) 2002; 103:283-293.
22. Demir M, Paydaş S, Cayli M, Akpinar O, Balal M, Acartürk E. Tissue Doppler is a more reliable method in early detection of cardiac dysfunction in patients with AA amyloidosis. Ren Fail 2005; 27:415-420.
23. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000; 102:470-479.
24. Kosmala W, Kucharski W, Przewlocka-Kosmala M, Mazurek W. Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am J Cardiol 2004; 94: 395-399.
25. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA 1991; 266:231-236.
26. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 2000; 97:1784-1789.
27. Villari B, Vassalli G, Schneider J, Chiariello M, Hess OM. Age dependency of left ventricular diastolic function in pressure overload hypertrophy. J Am Coll Cardiol 1997; 29:181-186.
28. Asbun J, Villarreal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006; 47:693-700.
29. Pacifico A, Henry PD. Structural pathways and prevention of heart failure and sudden death. J Cardiovasc Eiectrophysioi 2003; 14:764-775.
30. Frohlich ED. Potential mechanism explaining the risk of left ventricular hypertrophy. Am J Cardiol 1987; 59:91A-97A.
31. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004; 43:1399-1404.
32. Ogata T, Miyauchi T, Sakai S, Takanashi M, Irukayama-Tomobe Y, Yamaguchi I. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. J Am Coil Cardiol 2004; 43:1481-1488.
33. Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 2003; 107:2446-2452.
34. Vesely MR, Li S, Kop WJ, Reese A, Marshall J, Shorofsky SR, et al. Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. Am J Cardiol 2008; 101:645-650.